Code | CSB-RA022812A705phHU |
Size | US$210 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
Application | Recommended Dilution |
---|---|
WB | 1:500-1:5000 |
IHC | 1:50-1:200 |
In the development of the phospho-STAT3 (Tyr705) recombinant monoclonal antibody, the process kicks off with the retrieval of genes responsible for encoding this antibody from rabbits that have undergone immunization with a synthesized peptide derived from the human STAT3 protein phosphorylated at Tyr705. These antibody genes are subsequently cloned into specialized expression vectors. Following this genetic modification, the vectors are introduced into host suspension cells, which are carefully cultivated to stimulate the production and secretion of antibodies. Subsequently, the phospho-STAT3 (Tyr705) recombinant monoclonal antibody is subjected to a meticulous purification process utilizing affinity chromatography techniques, effectively isolating the antibody from the surrounding cell culture supernatant. Lastly, the functionality of the antibody is comprehensively evaluated through a diverse array of assays, including ELISA, WB, and IHC tests, unequivocally confirming its capacity to interact with the human STAT3 protein phosphorylated at Tyr705.
Phosphorylation of STAT3 at Tyr705 is a crucial regulatory event that controls its transcriptional activity and influences various cellular processes, including immune responses and cell fate decisions. Dysregulation of this phosphorylation event can have significant implications in cancer, inflammation, and other diseases.
There are currently no reviews for this product.